Pro Medicus’ wholly owned European subsidiary Visage Imaging has entered into an enterprise picture archiving and communication system (PACS) contract with University Hospital Heidelberg (UKHD) and German Cancer Research Institute (DKFZ), along with associated hospitals KKH Bergstrasse and Thoraxklinik Heidelberg.
This five-year contract, valued at A$10m ($6.5m), will replace and consolidate three legacy PACS systems across these institutions.
German academic medical centre UKHD has almost 14,000 staff members and approximately 2,600 beds.
The hospital is affiliated with the medical faculty of Heidelberg University and is situated near DKFZ, a biomedical research institution in Germany employing around 1,490 scientists.
Together with UKHD, DKFZ forms one of Europe's key centres for cancer treatment and research.
The institutions require technology to facilitate diagnostics, treatment pathways, and translational research. They depend on imaging for routine patient care, as well as to connect scientific discoveries with clinical applications.
The Visage 7 Enterprise Imaging Platform, which will be implemented at these hospitals, will facilitate access to imaging data sets across various research domains, institutions, and specialties.
Visage 7 aids in consolidating disparate legacy systems, streamlining workflows, and equipping clinicians with the necessary tools to interpret complex imaging studies effectively.
UKHD chief information officer Oliver Reinhard said: “Imaging is at the heart of both patient care and research at University Hospital Heidelberg. With Visage 7, we are gaining a futureproof platform that can support our clinicians with the most advanced diagnostic tools, while enabling researchers to work seamlessly with imaging data at scale.
“This is essential for our mission to translate scientific discoveries rapidly into improved outcomes for patients.”
Visage 7 also enables researchers to incorporate imaging into translational studies and clinical trials while establishing a solid foundation for translating new discoveries into clinical practice.
